News
ACHL
1.480
0.00%
0.00
Webull provides a variety of real-time ACHL stock news. You can receive the latest news about Achilles Therapeutics Plc through multiple platforms. This information may help you make smarter investment decisions.
About ACHL
Achilles Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company has been developing artificial intelligence (AI)-powered precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that are expressed on the surface of every cancer cell. The Company has used DNA sequencing data from each patient, together with its proprietary PELEUS bioinformatics platform, to identify clonal neoantigens specific to that patient, to enable and support development of product candidates specifically targeting those clonal neoantigens.